AU2014393402A1 - Therapeutic placental compositions, methods of making and methods of use - Google Patents

Therapeutic placental compositions, methods of making and methods of use Download PDF

Info

Publication number
AU2014393402A1
AU2014393402A1 AU2014393402A AU2014393402A AU2014393402A1 AU 2014393402 A1 AU2014393402 A1 AU 2014393402A1 AU 2014393402 A AU2014393402 A AU 2014393402A AU 2014393402 A AU2014393402 A AU 2014393402A AU 2014393402 A1 AU2014393402 A1 AU 2014393402A1
Authority
AU
Australia
Prior art keywords
placental
composition
tissue
cells
cryopreserved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014393402A
Other languages
English (en)
Inventor
Alla Danilkovitch
Timothy Jansen
Amy Elizabeth Johnson
Gabriele Putz TODD
Samson Tom
Dana Yoo
Jaime Zerhusen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osiris Therapeutics Inc
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Publication of AU2014393402A1 publication Critical patent/AU2014393402A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2014393402A 2014-05-07 2014-05-07 Therapeutic placental compositions, methods of making and methods of use Abandoned AU2014393402A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/037201 WO2015171142A1 (en) 2014-05-07 2014-05-07 Therapeutic placental compositions, methods of making and methods of use

Publications (1)

Publication Number Publication Date
AU2014393402A1 true AU2014393402A1 (en) 2016-11-24

Family

ID=54392804

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014393402A Abandoned AU2014393402A1 (en) 2014-05-07 2014-05-07 Therapeutic placental compositions, methods of making and methods of use

Country Status (7)

Country Link
EP (1) EP3139935A4 (ja)
JP (1) JP2017514876A (ja)
KR (1) KR20160147058A (ja)
AU (1) AU2014393402A1 (ja)
CA (1) CA2948126A1 (ja)
SG (1) SG11201609254YA (ja)
WO (1) WO2015171142A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11207353B2 (en) 2010-02-18 2021-12-28 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7011135B2 (ja) * 2016-02-19 2022-02-10 佳秀工業株式会社 血管内皮増殖因子産生促進剤の製造方法及び発毛剤の製造方法、並びに血管内皮増殖因子産生促進剤及び発毛剤
CA3016606A1 (en) * 2016-03-14 2017-09-21 Plakous Therapeutics, Inc. Acellular placental preparations
US10960027B2 (en) 2016-03-23 2021-03-30 Mimedx Group, Inc. Compositions and methods of treatment with amniotic fluid
NZ750363A (en) 2016-08-24 2021-12-24 Arthrex Inc Tissue use for repair of injury
WO2018144694A1 (en) 2017-02-01 2018-08-09 Plakous Therapeutics, Inc. Placental tissue compositions
US11511017B2 (en) 2019-03-12 2022-11-29 Arthrex, Inc. Ligament reconstruction
WO2021003257A1 (en) * 2019-07-01 2021-01-07 Auxocell Laboratories, Inc. Methods and compositions for collecting and using placental tissue cells and placental blood cells
US20210154240A1 (en) * 2019-11-21 2021-05-27 Bioventus, LLC. Placental Tissue Particulate Compositions and Methods of Use
WO2021123320A1 (en) * 2019-12-20 2021-06-24 Dr. Kalali Prof. Mostafazadeh Dipl. Ing. Miedl (Kmm) Gesellschaft Bürgerlichen Rechts A composition and its use for a universal therapy against tumor cells
KR102116954B1 (ko) * 2019-12-26 2020-05-29 주식회사 엠케이바이오텍 태아 유래 줄기세포의 동결 보존 및 동결 건조용 배지 조성물
WO2022074523A1 (en) * 2020-10-06 2022-04-14 Osiris Therapeutics, Inc. Primed placental tissue and uses in regenerative medicine
WO2022183100A1 (en) * 2021-02-26 2022-09-01 Crown Scientific, L.L.C. Villi stromal cells compositions and uses thereof
WO2023192484A2 (en) * 2022-04-01 2023-10-05 Bright Cell, Inc. A mesenchymal stem cells formulation for cosmetic use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335634A1 (en) * 2000-02-11 2011-06-22 The General Hospital Corporation Photochemical tissue bonding
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
PL1641914T3 (pl) * 2003-06-27 2017-01-31 DePuy Synthes Products, Inc. Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
EP2271208A1 (en) * 2008-03-27 2011-01-12 Biolife Solutions, Inc. Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue
WO2011103462A1 (en) * 2010-02-18 2011-08-25 Osiris Therapeutics, Inc. Methods of manufacture of immunocompatible amniotic membrane products
US8632512B2 (en) * 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US20140106447A1 (en) * 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11207353B2 (en) 2010-02-18 2021-12-28 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products

Also Published As

Publication number Publication date
JP2017514876A (ja) 2017-06-08
EP3139935A4 (en) 2017-11-15
EP3139935A1 (en) 2017-03-15
CA2948126A1 (en) 2015-11-12
KR20160147058A (ko) 2016-12-21
SG11201609254YA (en) 2016-12-29
WO2015171142A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
US11590173B2 (en) Methods of manufacture of therapeutic products comprising vitalized placental dispersions
US20150010506A1 (en) Therapeutic placental compositions, methods of making and methods of use
AU2014393402A1 (en) Therapeutic placental compositions, methods of making and methods of use
US20150010610A1 (en) Immunocompatible amniotic membrane products
US20150010609A1 (en) Immunocompatible chorionic membrane products
EP3139934A1 (en) Immunocompatible chorionic membrane products
EP3139936A1 (en) Immunocompatible amniotic membrane products

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period